Author:
Mrisho Mwifadhi,Mwangoka Grace,Ali Ali M.,Mkopi Abdallah,Mahende Muhidin K.,Temu Silas,Msuya Hajirani M.,Kazyoba Paul E.,Abdallah Gumi,Mihayo Michael,Juma Omar,Hamad Ali,Jongo Said,Lweno Omar,Tumbo Anneth,Mswata Sarah,Kassim Kamaka R.,Kishimba Rogath,Haruna Hussein,Kassa Hellen,Kapologwe Ntuli,Rashid Mohammed,Abdulla Salim
Abstract
AbstractA pilot implementation of the rapid diagnostic test program was performed to collect evidence of the feasibility, acceptability, and uptake of the COVID-19 AgRDT in Tanzania. We conducted a prospective cross-sectional study in the community to provide quantitative details of the pilot implementation of the antigen rapid diagnostic test (AgRDT) in Tanzania. This study was undertaken between March 2022 and September 2022. The pilot was implemented by distributing and offering test kits to people suspected of having COVID-19 in Dar es Salaam through community health workers. A total of 1039 participants consented to participate in the survey. All the participants reported having heard about the disease. The radio was the main source (93.2%) of information on COVID-19. With regard to prevention measures, approximately 930 (89.5%) of the respondents thought that COVID-19 could be prevented. Approximately 1035 (99.6%) participants reported that they were willing to have a COVID-19 AgRDT test and wait for 20 min for the results. With regard to the participants’ opinions on the AgRDT device, the majority 907 (87.3%) felt comfortable with the test, and 1,029 (99.0%) were very likely to recommend the AgRDT test to their friends. The majority of participants 848 (83.1%) mentioned that they would be willing to pay for the test if it was not available for free. The results suggest overall good acceptance of the COVID-19 AgRDT test. It is evident that the use of trained community healthcare workers allows easy screening of all possible suspects and helps them receive early treatment.
Funder
FIND | Campus Biotech, Chemin des Mines 9, 1202 Geneva, Switzerland
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. World Health Organization, SARS-CoV-2 antigen-detecting rapid diagnostic tests: An implementation guide (2020).
2. Jakobsen, K. K. et al. Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection. Dan Med. J. 68(7), A03210217 (2021).
3. Valentine-Graves, M. et al. At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: Postcollection acceptability of specimen collection process and patient confidence in specimens. PLoS one 15(8), e0236775 (2020).
4. Abdullahi, L. et al. Community interventions in Low—And Middle-Income Countries to inform COVID-19 control implementation decisions in Kenya: A rapid systematic review. PLoS One 15(12), e0242403 (2020).
5. Menni, C. et al. Widespread smell testing for COVID-19 has limited application–Authors’ reply. Lancet 396(10263), 1630–1631 (2020).